Baseline bone mineral density and bone metabolism markers in hormone receptor-positive breast cancer patients undergoing aromatase inhibitor treatment: a preliminary report from a randomized controlled trial

First Author / 第一作者

蔡易臻

Institution / 單位

Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital

Audio / 音訊檔

Author Group / 作者群

I-Chen Tsai

Author Group Institution/ 作者群單位

Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Division of Breast Surgery, Department of Surgery, Taichung Veterans General Hospital

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Aromatase inhibitor, Bone mineral density, Hormone receptor-positive breast cancer, Bone turnover markers

Back to list